Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SER120 in Nocturia
NCT01357356Phase 3Completed
- Sponsor
- Serenity Pharmaceuticals
- Start
- May 2011
- Primary completion
- Oct 2012
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in nocturia, sponsored by Serenity Pharmaceuticals. Started May 2011; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01357356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357356.